Summary:
Horizons Clinical Research Center, LLC is now enrolling participants in a research study for the treatment of moderate to severe plaque psoriasis. This study compares an investigational medication that combines two FDA approved psoriasis treatments to a single psoriasis medication currently on the market.
Qualified Participants Must:
• Be at least 18 years of age
•
Have at least 10% of the body surface area affected by the psoriasis
•
Have had stable plaque psoriasis for at least the past 6 months
Qualified Participants May Receive:
All study related clinic visits, lab assessments, medical exams, and study medication at no cost throughout the study, plus compensation for time and travel.